Cargando…
Repurposing UDCA, an FXR Inhibitor, to Prevent SARS-Cov-2 Infection
Autores principales: | Prayitno, Khairunnadiya, Bhat, Mamatha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850641/ https://www.ncbi.nlm.nih.gov/pubmed/36681157 http://dx.doi.org/10.1053/j.gastro.2023.01.014 |
Ejemplares similares
-
Multi-omic Characterization of COVID Hepatitis
por: Bhat, Mamatha
Publicado: (2022) -
UDCA, a novel strategy for preventing SARS-CoV-2 infection via FXR-mediated ACE2 downregulation: UDCA and SARS-CoV-2 infection
por: Chen, Mengjiao, et al.
Publicado: (2023) -
The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020) -
Blockade of SARS-CoV-2 infection by recombinant soluble ACE2
por: Alhenc-Gelas, Francois, et al.
Publicado: (2020) -
SFPH proteins as therapeutic targets for a myriad of diseases
por: Wang, Dong, et al.
Publicado: (2020)